Literature DB >> 16286446

Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication?

Karen B Hirschman1, Colette M Joyce, Bryan D James, Sharon X Xie, David J Casarett, Jason H T Karlawish.   

Abstract

OBJECTIVES: The authors examined the factors associated with 1) caregivers' willingness to involve a relative with Alzheimer disease (AD) in a decision to use an AD-slowing treatment; and 2) how caregivers would resolve a disagreement over this decision with the their relative.
METHODS: This was a cross-sectional interview study of 102 caregivers of patients with mild-to-severe-stage AD, enrolled in a University Memory Disorders Clinic.
RESULTS: Forty-four percent of caregivers (45/102) said that his or her relative would participate in a decision to use an AD-slowing treatment. Logistic regression showed that having less dementia severity, being a female caregiver, and a spousal relationship were all associated with caregivers' involving their relative in this decision. Among the caregivers who said they would involve their relative, the majority said they would resolve disagreements over whether to use the treatment in favor of what the patient wanted, versus what the family wanted for the patient. Male caregivers were less likely to resolve disagreements in favor of the patients' preferences.
CONCLUSION: Although most caregivers of patients in mild-to-moderate stages would include these patients in an AD treatment decision, certain caregiver characteristics, such as gender and relationship, are associated with not involving patients in this decision. Physicians working with dementia patients and their family members should take these characteristics into account when discussing treatment options and work with patient-caregiver dyads to improve the communication of preferences.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286446     DOI: 10.1176/appi.ajgp.13.11.1014

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  6 in total

1.  Key psychosocial interventions for Alzheimer's disease: an update.

Authors:  Edmund Howe
Journal:  Psychiatry (Edgmont)       Date:  2008-02

2.  Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics.

Authors:  Noam U Epstein; Andrew J Saykin; Shannon L Risacher; Sujuan Gao; Martin R Farlow
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

3.  Involvement of Hospitalized Persons With Dementia in Everyday Decisions: A Dyadic Study.

Authors:  Lyndsey M Miller; Christopher S Lee; Carol J Whitlatch; Karen S Lyons
Journal:  Gerontologist       Date:  2018-07-13

4.  Implications of FDA Approval of a First Disease-Modifying Therapy for a Neurodegenerative Disease on the Design of Subsequent Clinical Trials.

Authors:  Joshua D Grill; Jason Karlawish
Journal:  Neurology       Date:  2021-06-04       Impact factor: 11.800

5.  Patient's Cognitive Function and Attitudes towards Family Involvement in Cancer Treatment Decision Making: A Patient-Family Caregiver Dyadic Analysis.

Authors:  Dong Wook Shin; Juhee Cho; Debra L Roter; So Young Kim; Jong Hyock Park; Hyung Kook Yang; Hyun Woo Lee; Sun-Seog Kweon; Yune Sik Kang; Keeho Park
Journal:  Cancer Res Treat       Date:  2017-07-04       Impact factor: 4.679

6.  Using poetry as data to explore daily and formal care decision making within African American dementia dyads.

Authors:  Kalisha Bonds Johnson; Fayron R Epps; MinKyoung Song; Karen S Lyons; Martha Driessnack
Journal:  Geriatr Nurs       Date:  2021-06-05       Impact factor: 2.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.